[Acute lymphoblastic leukemia in adolescents]

Area of Science:

• Pediatric Hematology-Oncology
• Cancer Research
• Clinical Epidemiology

Context:

• Age is a recognized prognostic factor in acute lymphoblastic leukemia (ALL), with outcomes varying significantly across different pediatric age groups.
• Existing literature presents conflicting data regarding the prognosis for adolescents diagnosed with ALL.
• Understanding prognostic factors is crucial for tailoring treatment strategies and improving outcomes in pediatric ALL.

Purpose:

• To investigate the prognostic significance of age, specifically focusing on adolescents (10-15 years), in pediatric non-B acute lymphoblastic leukemia (ALL).
• To analyze presenting features and survival data of pediatric ALL patients treated under AIEOP protocols.
• To determine if advanced age at diagnosis (≥10 years) negatively impacts event-free survival in this cohort.

Summary:

• A retrospective analysis of 302 pediatric non-B ALL patients (1976-1992) revealed that adolescents (10-15 years) exhibited event-free survival rates (52%) comparable to younger children (51%).
• Despite a higher prevalence of unfavorable prognostic indicators in adolescents, including elevated hemoglobin, mediastinal mass, T-cell immunophenotype, and L2 morphology, their survival outcomes were not adversely affected.
• The study concludes that an age at diagnosis greater than 10 years is not an unfavorable prognostic factor within this specific patient population.

Impact:

• Challenges the established view of age as a consistent negative prognostic factor for adolescents with ALL.
• Provides evidence suggesting that treatment protocols may mitigate the impact of certain adverse prognostic factors in older pediatric ALL patients.
• Informs clinical decision-making and future research directions for optimizing ALL management in adolescent populations.